EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (4)
2024
-
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer
Cancer Epidemiology Biomarkers and Prevention, Vol. 33, Núm. 3, pp. 419-425
2015
-
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
British Journal of Cancer, Vol. 112, Núm. 7, pp. 1190-1198
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296
-
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, Vol. 32, Núm. 8, pp. 760-767